Adam S. Price MD , Akilah A. Jefferson-Shah MD , Robert D. Pesek MD , Erhan Ararat MD , Safia F. Nawaz MD , Matthew Pertzborn MD , Kim Cobb RT , Haley Long RT , Monica Y. Miller LMSW , Brandi N. Whitaker PhD , Stacie M. Jones MD , Scott Stewart MS , Daniel Liu MD , Tamara T. Perry MD
{"title":"Multidisciplinary care in pediatric severe asthma: A comparative outcomes analysis","authors":"Adam S. Price MD , Akilah A. Jefferson-Shah MD , Robert D. Pesek MD , Erhan Ararat MD , Safia F. Nawaz MD , Matthew Pertzborn MD , Kim Cobb RT , Haley Long RT , Monica Y. Miller LMSW , Brandi N. Whitaker PhD , Stacie M. Jones MD , Scott Stewart MS , Daniel Liu MD , Tamara T. Perry MD","doi":"10.1016/j.jacig.2025.100417","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>There are limited data comparing the effectiveness of multidisciplinary severe asthma clinics (SACs) with that of conventional single-discipline clinics (SDCs) for pediatric severe asthma.</div></div><div><h3>Objective</h3><div>Our aim was to compare asthma outcomes between SACs and SDCs clinics and examine longitudinal health outcomes for patients with severe asthma who were followed in SACs.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study comparing pediatric asthma outcomes among patients with severe asthma between 2018 and 2022 who were treated at the multidisciplinary Arkansas Children's SAC with those of patients with severe asthma treated at SDCs. The primary outcome was acute health care utilization, including hospitalizations and emergency department visits. Secondary outcomes included systemic corticosteroid prescriptions and controller medications. For SAC enrollees, longitudinal outcomes including health care utilization, symptom control, and spirometry were evaluated 12 months before and after enrollment. Data sources included the electronic health record and SAC patient registry.</div></div><div><h3>Results</h3><div>The study population included 280 patients with severe asthma, aged 5 to 18 years, from the SAC (n = 56) and SDCs (n = 224). The SAC patients were more likely to be Black (79% vs 52% [<em>P</em> = .0002]), be non-Hispanic (100% vs 88% [<em>P</em> = .01]), have had at least 1 hospitalization (21% vs 10% [<em>P</em> = .04]), and have received at least 2 prescriptions for a systemic corticosteroid (34% vs 17% [<em>P</em> = .01]). Longitudinal outcomes among patients for the 12 months before SAC enrollment versus 12 months after SAC enrollment demonstrated significant reductions in acute exacerbations (from 35 to 8 [<em>P</em> < .001]), hospitalizations (from 21 to 1 [<em>P</em> < .001]), and intensive care unit admissions (from 8 to 1 [<em>P</em> = .02]).</div></div><div><h3>Conclusions</h3><div>The study highlights significant morbidity among predominately Black pediatric patients with severe asthma, particularly those followed in a SAC versus in SDCs at a tertiary care referral center. The findings demonstrate the value of targeted multidisciplinary approaches to reduce asthma utilization and improve outcomes among high-risk patients.</div></div>","PeriodicalId":75041,"journal":{"name":"The journal of allergy and clinical immunology. Global","volume":"4 2","pages":"Article 100417"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of allergy and clinical immunology. Global","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772829325000189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
There are limited data comparing the effectiveness of multidisciplinary severe asthma clinics (SACs) with that of conventional single-discipline clinics (SDCs) for pediatric severe asthma.
Objective
Our aim was to compare asthma outcomes between SACs and SDCs clinics and examine longitudinal health outcomes for patients with severe asthma who were followed in SACs.
Methods
We conducted a retrospective cohort study comparing pediatric asthma outcomes among patients with severe asthma between 2018 and 2022 who were treated at the multidisciplinary Arkansas Children's SAC with those of patients with severe asthma treated at SDCs. The primary outcome was acute health care utilization, including hospitalizations and emergency department visits. Secondary outcomes included systemic corticosteroid prescriptions and controller medications. For SAC enrollees, longitudinal outcomes including health care utilization, symptom control, and spirometry were evaluated 12 months before and after enrollment. Data sources included the electronic health record and SAC patient registry.
Results
The study population included 280 patients with severe asthma, aged 5 to 18 years, from the SAC (n = 56) and SDCs (n = 224). The SAC patients were more likely to be Black (79% vs 52% [P = .0002]), be non-Hispanic (100% vs 88% [P = .01]), have had at least 1 hospitalization (21% vs 10% [P = .04]), and have received at least 2 prescriptions for a systemic corticosteroid (34% vs 17% [P = .01]). Longitudinal outcomes among patients for the 12 months before SAC enrollment versus 12 months after SAC enrollment demonstrated significant reductions in acute exacerbations (from 35 to 8 [P < .001]), hospitalizations (from 21 to 1 [P < .001]), and intensive care unit admissions (from 8 to 1 [P = .02]).
Conclusions
The study highlights significant morbidity among predominately Black pediatric patients with severe asthma, particularly those followed in a SAC versus in SDCs at a tertiary care referral center. The findings demonstrate the value of targeted multidisciplinary approaches to reduce asthma utilization and improve outcomes among high-risk patients.